These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1419985)

  • 21. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
    Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
    J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pathophysiological disorders and experimental therapy in pemphigus and pemphigoid].
    Grando SA; Glukhen'kiĭ BT; Barabash TM; Zaslavskiĭ LI; Cherniavskiĭ AI
    Vestn Dermatol Venerol; 1990; (11):4-9. PubMed ID: 2288153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphotoxin detected in the blister fluid of bullous pemphigoid patients.
    Jeffes EW; Yamamoto RS; Ahmed AR; Granger GA
    J Clin Immunol; 1984 Jan; 4(1):31-5. PubMed ID: 6365950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
    Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
    Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
    Kawachi Y; Otsuka F
    J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
    Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.
    Schmidt E; Bastian B; Dummer R; Tony HP; Bröcker EB; Zillikens D
    Arch Dermatol Res; 1996 Jun; 288(7):353-7. PubMed ID: 8818181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
    Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
    Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A possible interaction between periostin and CD163
    Fujimura T; Kakizaki A; Furudate S; Aiba S
    Exp Dermatol; 2017 Dec; 26(12):1193-1198. PubMed ID: 27501402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases.
    Wollina U; Lange D; Looks A
    Dermatology; 1999; 198(2):140-4. PubMed ID: 10325460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
    Dainichi T; Chow Z; Kabashima K
    J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques.
    Okubo K; Karashima T; Hachisuka H; Sasai Y
    Kurume Med J; 1989; 36(4):173-9. PubMed ID: 2700767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
    Kramer MD; Reinartz J
    J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bullous diseases in Malaysia: epidemiology and natural history.
    Adam BA
    Int J Dermatol; 1992 Jan; 31(1):42-5. PubMed ID: 1737688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line.
    Seishima M; Esaki C; Osada K; Mori S; Hashimoto T; Kitajima Y
    J Invest Dermatol; 1995 Jan; 104(1):33-7. PubMed ID: 7798638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lesional Th17 cells and regulatory T cells in bullous pemphigoid.
    Arakawa M; Dainichi T; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Tsuruta D; Hashimoto T
    Exp Dermatol; 2011 Dec; 20(12):1022-4. PubMed ID: 22017210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmin-like proteinase associated with high molecular weight complexes in blister fluid of bullous pemphigoid.
    Lauharanta J; Salonen EM; Vaheri A
    Acta Derm Venereol; 1989; 69(6):527-9. PubMed ID: 2575330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.